Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-31

FDA Approved: VOQUEZNA DUAL PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Voquezna Dual Pak, a combination of vonoprazan and amoxicillin from Phathom Pharmaceuticals, expanding its appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOQUEZNA DUAL PAK (Vonoprazan fumarate and amoxicillin)

Snippet

SUPPL AP for VOQUEZNA DUAL PAK (VONOPRAZAN FUMARATE AND AMOXICILLIN)